Giorgio Treglia

Prof. Dr. Giorgio Treglia

1. Ente Ospedaliero Cantonale - EOC, viale Officina 3, CH-6500, Bellinzona, Switzerland
+1
orcid

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 February 2012 in Endocrine
Verified
Journal Article
Closed access
PDF file
Giorgio TregliaGiorgio Treglia
Giorgio Treglia
PCPaola Castaldi
Paola Castaldi
Guido RindiGuido Rindi
Guido Rindi
AGAlessandro Giordano
Alessandro Giordano
VRVittoria Rufini
Vittoria Rufini

9 August 2018 in European Journal of Nuclear Medicine and Molecular Imaging
Verified
Journal Article
Closed access
PDF file
Giorgio TregliaGiorgio Treglia
Giorgio Treglia
Arnoldo PiccardoArnoldo Piccardo
Arnoldo Piccardo
AIAlessio Imperiale
Alessio Imperiale
KSKlaus Strobel
Klaus Strobel
PKPhilipp A. Kaufmann
Philipp A. Kaufmann
LGLuca Giovanella
Luca Giovanella

21 July 2014 in Clinical Endocrinology
Verified
Journal Article
Closed access
PDF file
PTPierpaolo Trimboli
Pierpaolo Trimboli
Giorgio TregliaGiorgio Treglia
Giorgio Treglia
Leo GuidobaldiLeo Guidobaldi
Leo Guidobaldi
FRFrancesco Romanelli
Francesco Romanelli
Giuseppe NigriGiuseppe Nigri
Giuseppe Nigri
LGLuca Giovanella
Luca Giovanella

1 November 2012 in The Journal of Clinical Endocrinology & Metabolism
Verified
Journal Article
Open access
PDF file
FBFrancesco Bertagna
Francesco Bertagna
Giorgio TregliaGiorgio Treglia
Giorgio Treglia
Arnoldo PiccardoArnoldo Piccardo
Arnoldo Piccardo
RGRaffaele Giubbini
Raffaele Giubbini
Context: Thyroid incidentaloma diagnosed by 2-[18F]-fluoro-2-deoxy-d-glucose positron emission tomography/computed tomography (F-18-FDG-PET/CT) is defined as a thyroid uptake incidentally and newly detected in a patient studied for nonthyroid purpose. In this review, we have comprehensively analyzed the diagnostic and clinical significance of F-18-FDG-PET/CT thyroid incidentalomas revealed during studies performed for an unrelated and nonthyroid purpose. Evidence Acquisition: A comprehensive literature research of the PubMed/MEDLINE databases was conducted to find relevant published articles about the F-18-FDG-PET or F-18-FDG-PET/CT thyroid incidentalomas. Evidence Synthesis: All studies considered in this review have investigated a very large number of patients, achieving overall about 147,505 units. The pooled incidence of thyroid incidentalomas detected by F-18-FDG-PET or PET/CT was 2.46% (95% confidence interval, 1.68–3.39%). The malignancy ratio was 34.6% (95% confidence interval, 29.3–40.2%). Conclusion: F-18-FDG-PET/CT thyroid incidentaloma is a relevant clinical finding; diffuse uptakes and most focal uptakes are commonly caused by benign diseases, whereas about one third of focal uptakes are malignant; the most frequent malignant histological type responsible for F-18-FDG-PET/CT thyroid incidentaloma is papillary thyroid carcinoma.

6 January 2012 in European Journal of Nuclear Medicine and Molecular Imaging
Verified
Journal Article
Closed access
PDF file
Giorgio TregliaGiorgio Treglia
Giorgio Treglia
PCPaola Castaldi
Paola Castaldi
MVMaria Felicia Villani
Maria Felicia Villani
GPGermano Perotti
Germano Perotti
Chiara de WaureChiara de Waure
Chiara de Waure
VRVittoria Rufini
Vittoria Rufini

6 November 2019 in The Journal of Clinical Endocrinology & Metabolism
Verified
Journal Article
Closed access
PDF file
MCMarco Castellana
Marco Castellana
CCCarlo Castellana
Carlo Castellana
Giorgio TregliaGiorgio Treglia
Giorgio Treglia
Francesco GiorginoFrancesco Giorgino
Francesco Giorgino
LGLuca Giovanella
Luca Giovanella
PTPierpaolo Trimboli
Pierpaolo Trimboli
Context: Ultrasound (US) risk stratification systems (RSSs) have been developed to reduce the number of unnecessary fine-needle aspiration procedures (FNA) in patients with thyroid nodules.Objective: We conducted a systematic review and meta-analysis evaluating the ability of the 5 most common US RSSs for the appropriate selection of thyroid nodules for FNA.Data sources: This systematic review and meta-analysis was registered on PROSPERO (CRD42019131771). PubMed, CENTRAL, Scopus, and Web of Science were searched until March 2019.Study selection: Original articles reporting data on the performance of AACE/ACE/AME, ACR TI-RADS, ATA, EU-TIRADS, and K-TIRADS were included.Data extraction: The number of nodules classified as true negative, true positive, false negative, and false positive was extracted. Summary operating points were estimated using a random-effects model. Interobserver agreement was also assessed.Data synthesis: Twelve studies evaluating 18 750 thyroid nodules were included. Participants were adult outpatients with thyroid nodules submitted to either FNA or core-needle biopsy or surgery and with available US images. The final diagnosis for malignant nodules was generally based on histology, while cytology was used for benign nodules. Diagnostic odds ratio (DOR) ranged from 2.2 to 4.9. A head-to-head comparison showed a higher relative DOR for ACR-TIRADS versus ATA (P = .002) or K-TIRADS (P = .002), due to a higher relative likelihood ratio for positive results.Conclusions: The present meta-analysis found a higher performance of ACR TI-RADS in selecting thyroid nodules for FNA. However, the comparison across the most common US RSSs was limited by the data available. Further studies are needed to confirm this finding.